# Tumour-immunology Journal-sweep

Slides and articles from tumour-immunology journal-sweep meetings.

### 28th of September, 2016

<b>Slide-deck:</b> <a href="https://drive.google.com/file/d/0Bz7jHjHQ8OpWNU1fQ1dBRzNCTTA/view?usp=sharing">Slides</a>.

<b>Articles:</b>

1. Cell: Singer M et al, <a href="https://www.ncbi.nlm.nih.gov/pubmed/27610572">A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells</a>.

2. Cancer Cell: Young A et al, <a href="https://www.ncbi.nlm.nih.gov/pubmed/27622332">Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses.</a>.

3. Cancer Cell: Liu Y et al, <a href="https://www.ncbi.nlm.nih.gov/pubmed/27505671">Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils</a>.

4. Nature Biotech: Bentzen AK et al, <a href="https://www.ncbi.nlm.nih.gov/pubmed/27571370">Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes</a>.

### 25th of August, 2016

<b>Slide-deck:</b> <a href="https://drive.google.com/file/d/0Bz7jHjHQ8OpWYk1RTDhULUlUTjA/view?usp=sharing">Slides</a>.

<b>Articles:</b>

1. Immunity: Scharping NE et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27496732">The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction</a>.

2. Cancer Cell: Roberts EW et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27424807">Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma</a>.

3. Cancer Research: Walton J et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27530326">CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high grade serous carcinoma.</a>.

4. Cell: Denny SK et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27374332">Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility</a>.

### 23th of June, 2016

<b>Slide-deck:</b> 
<a href="https://drive.google.com/open?id=0Bz7jHjHQ8OpWOXFrU0FYbzIzYUk">Slides</a>.

<b>Articles:</b>

1. Nature Cell Biology: Baer C et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27295554">Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity</a>.

2. Nature: Kranz LM et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27281205">Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy</a>.

3. Science: Strønen E et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27198675">Targeting of cancer neoantigens with donor-derived T cell receptor repertoires</a>.

4. Immunity: Ho SS et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27178469">The DNA Structure-Specific Endonuclease MUS81 Mediates DNA Sensor STING-Dependent Host Rejection of Prostate Cancer Cells</a>.

### 26th of May, 2016

<b>Slide-deck:</b> 
<a href="https://drive.google.com/file/d/0Bz7jHjHQ8OpWaHVFUWtJeU1DZ0E/view?usp=sharing">Slides</a>

<b>Articles:</b>

1. Cancer cell: Halama N et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27070705">Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients</a>.

2. Nature Biotechnology: Liu L et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/26900664">Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy</a>.

3. Cell: Wang W et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27133165">Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer</a>.

4. PNAS: Demaria O et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/26607445">STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity</a>.

5. Immunity: Tinoco R et al, <a href="http://www.ncbi.nlm.nih.gov/pubmed/27192578">PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion</a>.
